AH amyloidosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:442582E85.9
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

AH amyloidosis is a rare form of amyloidosis caused by the abnormal buildup of a protein called heavy chain immunoglobulin (specifically the heavy chain fragment, abbreviated 'AH') in tissues and organs throughout the body. Amyloidosis is a group of diseases where proteins fold into the wrong shape and clump together, forming deposits called amyloid fibrils. These deposits are like sticky plaques that build up inside organs and slowly damage them over time. In AH amyloidosis, the abnormal protein usually comes from a type of blood cell called a plasma cell, which is found in the bone marrow. When these cells produce too much or abnormal heavy chain protein, it can deposit in organs such as the kidneys, heart, liver, and digestive tract. This can lead to organ damage and a wide range of symptoms depending on where the deposits form. Symptoms can include swelling, fatigue, kidney problems, and heart issues. Treatment focuses on reducing the production of the abnormal protein — often by targeting the underlying plasma cell disorder — and managing organ damage. Because this condition is very rare, treatment is often guided by specialists in amyloidosis and blood disorders. Early diagnosis is important to protect organ function.

Also known as:

Key symptoms:

Swelling in the legs, ankles, or around the eyesExtreme tiredness or fatigueKidney problems, including protein in the urine (foamy urine)Shortness of breathIrregular heartbeat or heart failure symptomsEnlarged liver or spleenUnintended weight lossNumbness or tingling in the hands or feetDiarrhea, constipation, or other digestive problemsLow blood pressure when standing up (dizziness on standing)

Clinical phenotype terms (8)— hover any for plain English
Renal amyloidosisHP:0001917Cardiac amyloidosisHP:0030843ParaproteinemiaHP:0031047Elevated circulating NT-proBNP concentrationHP:0031185Amyloidosis of peripheral nervesHP:0100292
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for AH amyloidosis.

View clinical trials →

No actively recruiting trials found for AH amyloidosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the AH amyloidosis community →

No specialists are currently listed for AH amyloidosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to AH amyloidosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open AH amyloidosisForum →

No community posts yet. Be the first to share your experience with AH amyloidosis.

Start the conversation →

Latest news about AH amyloidosis

No recent news articles for AH amyloidosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which organs are affected in my case, and how severe is the damage so far?,What treatment do you recommend for my underlying plasma cell disorder, and what are the side effects?,Am I a candidate for stem cell transplant, and what would that process involve?,How will we monitor whether treatment is working and whether my organs are improving or stable?,Should I be seen at a specialized amyloidosis center, and can you refer me to one?,Are there any clinical trials I might be eligible for?,What dietary or lifestyle changes should I make to protect my kidneys and heart?

Common questions about AH amyloidosis

What is AH amyloidosis?

AH amyloidosis is a rare form of amyloidosis caused by the abnormal buildup of a protein called heavy chain immunoglobulin (specifically the heavy chain fragment, abbreviated 'AH') in tissues and organs throughout the body. Amyloidosis is a group of diseases where proteins fold into the wrong shape and clump together, forming deposits called amyloid fibrils. These deposits are like sticky plaques that build up inside organs and slowly damage them over time. In AH amyloidosis, the abnormal protein usually comes from a type of blood cell called a plasma cell, which is found in the bone marrow.

How is AH amyloidosis inherited?

AH amyloidosis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does AH amyloidosis typically begin?

Typical onset of AH amyloidosis is adult. Age of onset can vary across affected individuals.